ATE504332T1 - Verbindungen, zusammensetzungen, formulierungen und herstellungsverfahren dafür, behandlungsverfahren, handhabung von übersäuerung und verwandte erkrankungen - Google Patents

Verbindungen, zusammensetzungen, formulierungen und herstellungsverfahren dafür, behandlungsverfahren, handhabung von übersäuerung und verwandte erkrankungen

Info

Publication number
ATE504332T1
ATE504332T1 AT05815862T AT05815862T ATE504332T1 AT E504332 T1 ATE504332 T1 AT E504332T1 AT 05815862 T AT05815862 T AT 05815862T AT 05815862 T AT05815862 T AT 05815862T AT E504332 T1 ATE504332 T1 AT E504332T1
Authority
AT
Austria
Prior art keywords
methods
preparation
acidity
formulations
compositions
Prior art date
Application number
AT05815862T
Other languages
English (en)
Inventor
Chitra Vasant Savangikar
Vasant Anantrao Savangikar
Original Assignee
Chitra Vasant Savangikar
Vasant Anantrao Savangikar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chitra Vasant Savangikar, Vasant Anantrao Savangikar filed Critical Chitra Vasant Savangikar
Application granted granted Critical
Publication of ATE504332T1 publication Critical patent/ATE504332T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AT05815862T 2004-09-01 2005-08-30 Verbindungen, zusammensetzungen, formulierungen und herstellungsverfahren dafür, behandlungsverfahren, handhabung von übersäuerung und verwandte erkrankungen ATE504332T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN947MU2004 2004-09-01
PCT/IN2005/000289 WO2006025072A2 (en) 2004-09-01 2005-08-30 Compounds, compositions, formulations and process for preparation thereof and method of treatment and management of acidity and related disorders

Publications (1)

Publication Number Publication Date
ATE504332T1 true ATE504332T1 (de) 2011-04-15

Family

ID=35610051

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05815862T ATE504332T1 (de) 2004-09-01 2005-08-30 Verbindungen, zusammensetzungen, formulierungen und herstellungsverfahren dafür, behandlungsverfahren, handhabung von übersäuerung und verwandte erkrankungen

Country Status (5)

Country Link
US (1) US20080103089A1 (de)
EP (2) EP1796696B1 (de)
AT (1) ATE504332T1 (de)
DE (1) DE602005027367D1 (de)
WO (1) WO2006025072A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2298090T3 (pl) 2009-08-26 2016-07-29 Jeffrey M Golini Kompozycja farmaceutyczna lub nutraceutyczna
CN110157762A (zh) * 2019-07-16 2019-08-23 烟台市华昕生物医药科技有限公司 一种三文鱼寡肽及其制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US585758A (en) * 1897-07-06 Method of preparing edible tablets
GB886170A (en) * 1960-03-02 1962-01-03 Reheis Company Inc Aluminium protein antacid and process of making
FR4710M (de) * 1965-04-30 1967-01-02
US3735007A (en) * 1970-09-21 1973-05-22 Bristol Myers Co Clear liquid laxative-antacid composition
US3959246A (en) * 1974-07-08 1976-05-25 The United States Of America As Represented By The Secretary Of Agriculture Preparation of soluble edible protein from leafy green crops
HU174943B (hu) * 1976-06-30 1980-04-28 Vepex Foevallalkozasi Iroda Rt Sposob poluchenija koncentratov rastitel'nogo belka i pigmenta
JPH05194225A (ja) * 1991-11-07 1993-08-03 Yoshitomi Pharmaceut Ind Ltd 安定化された抗潰瘍剤含有製剤
WO1999025197A1 (en) * 1997-11-18 1999-05-27 Nutricept, Inc. Fenugreek compositions having reduced taste and odor and methods of use
CN1245074A (zh) * 1998-04-26 2000-02-23 曾忠铭 减弱阴道酸度的药剂和用途
MXPA00012399A (es) * 1998-06-10 2003-07-14 Albert B Crum Complememnto nutricional profilactico y terapeutico para la creacion y mantenimiento de microflora intestinal protectora de la salud y mejoramiento del sistema inmunologico.
US8337915B2 (en) * 2004-01-10 2012-12-25 S George Aburdeineh Fenugreek seed extract to lower blood cholesterol

Also Published As

Publication number Publication date
EP1796696A2 (de) 2007-06-20
DE602005027367D1 (de) 2011-05-19
US20080103089A1 (en) 2008-05-01
EP1796696B1 (de) 2011-04-06
WO2006025072A3 (en) 2006-05-18
WO2006025072A2 (en) 2006-03-09
WO2006025072B1 (en) 2006-06-29
EP2272523A1 (de) 2011-01-12

Similar Documents

Publication Publication Date Title
ATE486587T1 (de) Formulierungen zur oralen verabreichung von wirkstoffen
BRPI0411241A (pt) agentes terapêuticos úteis para o tratamento de dor
ATE411280T1 (de) Phenoxyessigsäure-derivate zur behandlung von störungen der atemwege
DE60318193D1 (en) Phenethanolaminderivate
SE0301010D0 (sv) Novel compounds
CY1110318T1 (el) Παραγωγα φαινοξυοξικου οξεος
DE60315492D1 (de) Medizinisch verwendbare arylethanolamin verbindungen
ATE381537T1 (de) Formanilid-derivative als beta2-adrenorezeptor- agonisten
ATE365720T1 (de) Agonisten von beta-adrenorezeptoren
MXPA03011484A (es) Heteroarilos multiciclicos sustituidos con quinuclidinas para el tratamiento de enfermedades.
BRPI0508579A (pt) composto, composição farmacêutica, e, uso de um composto
NO20064078L (no) Substituerte azetidinsammensetninger, deres fremstilling og anvendelse som medikamenter
MX2009005622A (es) Dihidro-imidazoles sustituidos y su uso en el tratamiento de tumores.
NO20071314L (no) Peptidiske vasopressinreseptoragonister
BR0211118A (pt) Composto, métodos para o tratamento ou prevenção de doenças e para fabricar um composto, intermediário, e, uso de um composto ou sal
DE602004008959D1 (de) Benzoäbüä1,4üdioxepinderivate
EE200400031A (et) Biokeemiliste ühendite kompositsioon, selle kasutamine maatriks-metalloproteinaaside pärssimiseks ning seda sisaldav ravimpreparaat
EA200701615A1 (ru) Новые лекарственные средства для лечения заболеваний дыхательных путей
BR0210392A (pt) Composto, métodos de tratar um paciente que tenha ou de prevenir um paciente de contrair uma doença ou condição e de preparar um composto, e, uso de um composto
DE60035429D1 (de) Verwendung von sulfodehydroabietinsäure zur behandlung entzündlicher darmerkrankungen
DE60225143D1 (de) Synergistische pharmazeutische zusammensetzungen zur behandlung bzw. prophylaxe von diabetes
SE0303480D0 (sv) Benzofuranes
BRPI0519152A2 (pt) composto ou um sal ou derivado Éster farmaceuticamente aceitÁvel do mesmo, formulaÇço farmacÊutica, formulaÇÕes para tratar osteoporose e psorÍase, uso de um composto ou de um sal farmaceuticamente aceitÁvel do mesmo, e, composiÇço farmacÊutica
TW200634002A (en) Chemical compounds
ATE432936T1 (de) Imidazotriazin verbindungen zur behandlung von krebserkrankungen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties